Sweet Syndrome Following SARS-CoV2 Vaccination

被引：18

作者：

Baffa, Maria Efenesia ^{[1
]}

Maglie, Roberto ^{[1
]}

Giovannozzi, Neri ^{[2
]}

Montefusco, Francesca ^{[1
]}

Senatore, Stefano ^{[1
]}

Massi, Daniela ^{[2
]}

Antiga, Emiliano ^{[1
]}

机构：

[1] Univ Florence, Dermatol Sect, Dept Hlth Sci, I-50125 Florence, Italy

[2] Univ Florence, Sect Pathol Anat, Dept Hlth Sci, I-50139 Florence, Italy

来源：

VACCINES | 2021年 / 9卷 / 11期

关键词：

Sweet's syndrome; mRNA vaccines; neutrophilic dermatoses; adverse event; FEBRILE NEUTROPHILIC DERMATOSIS; MOLECULES;

D O I：

10.3390/vaccines9111212

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Vaccines are today considered one of the most effective means against the Sars-CoV-2 pandemic. The BNT162b2 vaccine by Pfizer/BioNTech has been massively administered throughout the globe; since its approval, a wide spectrum of cutaneous reactions has been reported. Here we report the case of a 52-year-old Caucasian male who presented with an acute febrile eruption that arose 72 h after the first dose of the BNT162b2 vaccine. The clinicopathological findings were consistent with Sweet's syndrome. The short latency time suggested a possible role of the vaccine in triggering Sweet's syndrome in this case.

引用

收藏

页数：5

相关论文

共 23 条

[1] T helper type 1-related molecules as well as interleukin-15 are hyperexpressed in the skin lesions of patients with pyoderma gangrenosum [J].

Antiga, E. ;

Maglie, R. ;

Volpi, W. ;

Bianchi, B. ;

Berti, E. ;

Marzano, A. V. ;

Caproni, M. .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2017, 189 (03) :383-391

[2] Sweet's Syndrome Three Weeks after a Severe COVID-19 Infection: A Case Report [J].

Berro, Simar ;

Calas, Albane ;

Sohier, Pierre ;

Darbord, Delphine ;

Dupin, Nicolas .

ACTA DERMATO-VENEREOLOGICA, 2021, 101

[3] AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: A case report [J].

Capassoni, Marco ;

Ketabchi, Sheyda ;

Cassisa, Angelo ;

Caramelli, Riccardo ;

Molinu, Anna A. ;

Galluccio, Felice ;

Guiducci, Serena .

JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (10) :5718-5720

[4] Sweet's syndrome after BCG vaccination [J].

Carpentier, O ;

Piette, F ;

Delaporte, E .

ACTA DERMATO-VENEREOLOGICA, 2002, 82 (03) :221-221

[5] Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine [J].

Darrigade, Anne-Sophie ;

Theophile, Helene ;

Sanchez-Pena, Paola ;

Milpied, Brigitte ;

Colbert, Marianne ;

Pedeboscq, Stephane ;

Pistone, Thierry ;

Jullie, Marie-Laure ;

Seneschal, Julien .

ALLERGY, 2021, 76 (10) :3194-3196

[6]

European Medicines Agency, European Commission-DG Health and Food Safety and European Medicines Agency action plan on ATMPs

[7]

European Medicines Agency, COV 19 MRNA VACC COM

[8] Insights Into the Pathogenesis of Sweet's Syndrome [J].

Heath, Michael S. ;

Ortega-Loayza, Alex G. .

FRONTIERS IN IMMUNOLOGY, 2019, 10

[9] Acute febrile neutrophilic dermatosis (Sweet's syndrome) after influenza vaccination [J].

Jovanovic, M ;

Poljacki, M ;

Vujanovic, L ;

Duran, V .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (02) :367-369

[10] Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination [J].

Larson, Valerie ;

Seidenberg, Roy ;

Caplan, Avrom ;

Brinster, Nooshin K. ;

Meehan, Shane A. ;

Kim, Randie H. .

JOURNAL OF CUTANEOUS PATHOLOGY, 2022, 49 (01) :34-41